News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Local

Heavy Rain Floods Dana-Thomas House

Fresh
dana_thomas

Tours suspended

in Local

Quinn v Rauner on Minimum Wage

Bruce Rauner (R), Pat Quinn

Both candidates for governor say they support raising the state’s minimum wage—but under different circumstances

in Local

Durbin Says President Should Take Unilateral Action on Immigration Reform

immigration

Durbin is encouraging the president to unilaterally deal with issues surrounding the unaccompanied children coming to the U.S. border

in Local

State Will Stop Charging Retirees Premiums

Health

Local ruling is in line with state Supreme Court

in Local

Flooding Thursday

flood3

Some power is still out, says CWLP